Characterization of the expression of the hypoxia-induced genes neuritin, TXNIP and IGFBP3 in cancer

FEBS Letters

Volumn 580, Issue 14, 2006, Pages 3395-3400

  Le Jan, Sébastien ^a,b   Le Meur, Nolwenn ^a,c   Cazes, Aurélie ^a,b   Philippe, Josette ^a,b   Le Cunff, Martine ^a,c   Léger, Jean ^a,c   Corvol, Pierre ^a,b   Germain, Stéphane ^a,b,d  

^a INSERM   (France)

^b Paris Sciences et Lettres   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Angiogenesis; Endothelial cell; Gene expression; Hypoxia; Tumor marker

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT; NEURITIN; PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GENETICS; CANCER GROWTH; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE INDUCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HYPOXIA; IN SITU HYBRIDIZATION; MICROARRAY ANALYSIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION;

ANOXIA; CARRIER PROTEINS; CELLS, CULTURED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; NEOPLASMS; NEUROPEPTIDES; THIOREDOXIN;

EID: 33646943257     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.05.011     Document Type: Article

References (39)

1. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3 (1997) 177-182
2. 2 homeostasis. Curr. Opin. Genet. Dev. 8 (1998) 588-594
3. Brahimi-Horn C., Mazure N., and Pouyssegur J. Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications. Cell Signal. 17 (2005) 1-9
4. Masson N., and Ratcliffe P.J. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels. J. Cell. Sci. 116 (2003) 3041-3049
5. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307 (2005) 58-62
6. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann. Surg. 175 (1972) 409-416
7. Lal A., Peters H., St Croix B., Haroon Z.A., Dewhirst M.W., Strausberg R.L., Kaanders J.H., van der Kogel A.J., and Riggins G.J. Transcriptional response to hypoxia in human tumors. J. Natl. Cancer Inst. 93 (2001) 1337-1343
8. St Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., and Kinzler K.W. Genes expressed in human tumor endothelium. Science 289 (2000) 1197-1202
9. Scheurer S.B., Rybak J.N., Rosli C., Neri D., and Elia G. Modulation of gene expression by hypoxia in human umbilical cord vein endothelial cells: a transcriptomic and proteomic study. Proteomics 4 (2004) 1737-1760
10. Ning W., Chu T.J., Li C.J., Choi A.M., and Peters D.G. Genome-wide analysis of the endothelial transcriptome under short-term chronic hypoxia. Physiol. Genomics 18 (2004) 70-78
11. Manalo D.J., Rowan A., Lavoie T., Natarajan L., Kelly B.D., Ye S.Q., Garcia J.G., and Semenza G.L. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105 (2005) 659-669
12. Hubank M., and Schatz D.G. cDNA representational difference analysis: a sensitive and flexible method for identification of differentially expressed genes. Methods Enzymol. 303 (1999) 325-349
13. Pastorian K., Hawel III L., and Byus C.V. Optimization of cDNA representational difference analysis for the identification of differentially expressed mRNAs. Anal. Biochem. 283 (2000) 89-98
14. Le Jan S., Amy C., Cazes A., Monnot C., Lamande N., Favier J., Philippe J., Sibony M., Gasc J.M., Corvol P., and Germain S. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am. J. Pathol. 162 (2003) 1521-1528
15. Diehn M., Sherlock G., Binkley G., Jin H., Matese J.C., Hernandez-Boussard T., Rees C.A., Cherry J.M., Botstein D., Brown P.O., and Alizadeh A.A. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res. 31 (2003) 219-223
16. Steenman M., Lamirault G., Le Meur N., Le Cunff M., Escande D., and Leger J.J. Distinct molecular portraits of human failing hearts identified by dedicated cDNA microarrays. Eur. J. Heart Fail. 7 (2005) 157-165
17. Le Meur N., Lamirault G., Bihouee A., Steenman M., Bedrine-Ferran H., Teusan R., Ramstein G., and Leger J.J. A dynamic, web-accessible resource to process raw microarray scan data into consolidated gene expression values: importance of replication. Nucleic Acids Res. 32 (2004) 5349-5358
18. Tseng G.C., Oh M.K., Rohlin L., Liao J.C., and Wong W.H. Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects. Nucleic Acids Res. 29 (2001) 2549-2557
19. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., and Speed T.P. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30 (2002) e15
20. Smyth, G.K. (2004) in: Statistical Applications in Genetics and Molecular Biology, vol. 3, No. 1, Article 3.
21. Naeve G.S., Ramakrishnan M., Kramer R., Hevroni D., Citri Y., and Theill L.E. Neuritin: a gene induced by neural activity and neurotrophins that promotes neuritogenesis. Proc. Natl. Acad. Sci. USA 94 (1997) 2648-2653
22. Kojima N., Shiojiri N., Sakai Y., and Miyajima A. Expression of neuritin during liver maturation and regeneration. FEBS Lett. 579 (2005) 4562-4566
23. Nedivi E., Wu G.Y., and Cline H.T. Promotion of dendritic growth by CPG15, an activity-induced signaling molecule. Science 281 (1998) 1863-1866
24. Javaherian A., and Cline H.T. Coordinated motor neuron axon growth and neuromuscular synaptogenesis are promoted by CPG15 in vivo. Neuron. 45 (2005) 505-512
25. Eichmann A., Le Noble F., Autiero M., and Carmeliet P. Guidance of vascular and neural network formation. Curr. Opin. Neurobiol. 15 (2005) 108-115
26. Onita T., Ji P.G., Xuan J.W., Sakai H., Kanetake H., Maxwell P.H., Fong G.H., Gabril M.Y., Moussa M., and Chin J.L. Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer. Clin. Cancer Res. 8 (2002) 471-480
27. Raggo C., Ruhl R., McAllister S., Koon H., Dezube B.J., Fruh K., and Moses A.V. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res. 65 (2005) 5084-5095
28. Nishiyama A., Matsui M., Iwata S., Hirota K., Masutani H., Nakamura H., Takagi Y., Sono H., Gon Y., and Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 274 (1999) 21645-21650
29. Han S.H., Jeon J.H., Ju H.R., Jung U., Kim K.Y., Yoo H.S., Lee Y.H., Song K.S., Hwang H.M., Na Y.S., Yang Y., Lee K.N., and Choi I. VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22 (2003) 4035-4046
30. Cheng G.C., Schulze P.C., Lee R.T., Sylvan J., Zetter B.R., and Huang H. Oxidative stress and thioredoxin-interacting protein promote intravasation of melanoma cells. Exp. Cell Res. 300 (2004) 297-307
31. Ikarashi M., Takahashi Y., Ishii Y., Nagata T., Asai S., and Ishikawa K. Vitamin D3 up-regulated protein 1 (VDUP1) expression in gastrointestinal cancer and its relation to stage of disease. Anticancer Res. 22 (2002) 4045-4048
32. Feldser D., Agani F., Iyer N.V., Pak B., Ferreira G., and Semenza G.L. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 59 (1999) 3915-3918
33. Koong A.C., Denko N.C., Hudson K.M., Schindler C., Swiersz L., Koch C., Evans S., Ibrahim H., Le Q.T., Terris D.J., and Giaccia A.J. Candidate genes for the hypoxic tumor phenotype. Cancer Res. 60 (2000) 883-887
34. Tucci M., Nygard K., Tanswell B.V., Farber H.W., Hill D.J., and Han V.K. Modulation of insulin-like growth factor (IGF) and IGF binding protein biosynthesis by hypoxia in cultured vascular endothelial cells. J. Endocrinol. 157 (1998) 13-24
35. Fraser H.M., Lunn S.F., Kim H., and Erickson G.F. Insulin-like growth factor binding protein-3 mRNA expression in endothelial cells of the primate corpus luteum. Hum. Reprod. 13 (1998) 2180-2185
36. Schmid M.C., Bisoffi M., Wetterwald A., Gautschi E., Thalmann G.N., Mitola S., Bussolino F., and Cecchini M.G. Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels. Int. J. Cancer. 103 (2003) 577-586
37. Cheung C.W., Vesey D.A., Nicol D.L., and Jonhson D.W. The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney Int. 65 (2004) 1272-1279
38. Franklin S.L., Ferry Jr. R.J., and Cohen P. Rapid insulin-like growth factor (IGF)-independent effects of IGF binding protein-3 on endothelial cell survival. J. Clin. Endocrinol. Metab. 88 (2003) 900-907
39. Iwatsuki K., Tanaka K., Kaneko T., Kazama R., Okamoto S., Nakayama Y., Ito Y., Satake M., Takahashi S.I., Miyajima A., Watanabe T., and Hara T. Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3. Oncogene 24 (2005) 1129-1137